Moxifloxacin_QT Study in Chinese Healthy Volunteer
Status:
Unknown status
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
A single-center, randomized, double-blinded, 2-way crossover, placebo-controlled study to
assess the QTc interval after administration of single oral dose of 400mg Moxifloxacin in
healthy Chinese subjects.
Phase:
N/A
Details
Lead Sponsor:
Peking University Third Hospital
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination